Skip to main content

Fairmount Funds Management LLC

SEC CIK
0001802528
Latest filing
Aug 14, 2026

DMRA holding history

Damora Therapeutics, Inc. in every 13F filed by Fairmount Funds Management LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DMRA overviewAll 13F holders of DMRAFull Q2 2026 holdings

Shares (Q2 2026)
8,713,000
Value
$226.6M
% of portfolio
15.0%
Quarters held
2
Since Q1 2026
Holdings of DMRA by Fairmount Funds Management LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20268,713,000$226.6M15.0%00.0%UnchangedHolders
Q1 20268,713,000$225.7M16.3%+8,713,000NewHolders